Association of NFKB1 gene rs28362491 mutation with the occurrence of major adverse cardiovascular events
Open Access
- 13 July 2022
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 22 (1) , 1-6
Abstract
Background: Several studies have reported that NFKB1 gene rs28362491 polymorphism was associated with susceptibility to coronary heart disease in populations of different genetic backgrounds. To date, there have been no studies on the association between NFKB1 gene rs28362491 polymorphism and the occurrence of major adverse cardiac and cerebrovascular event (MACCE). The present study was to explore the relationship between NFKB1 gene rs28362491 polymorphism and MACCEs to investigate whether identifying NFKB1 gene polymorphism is beneficial to evaluating MACCE risks and patients’ prognoses. Methods: We recruited 257 high-risk of cardiovascular disease patients with chest pain or precordial discomfort. The SNPscan™ were used to analyze the NFKB1 gene rs28362491 polymorphism. All patients were followed up in the clinic or by telephone interview for MACCEs. Results: During the followed-up time (mean: 30.1 months) 49 patients had MACCEs (19.1%). Patients with the different genotypes of NFKB1 rs28362491 had different incidence rate of MACCE. The incidence of MACCE in patients carried II, ID and DD genotype was 16.5%, 15.9%, 32.6%, respectively. Log-rank analysis showed that the survival rate in patients with NFKB1 rs28362491 DD genotype was much lower than that in II or ID genotype carriers (P = 0.034). After excluding the influence of traditional risk factors of MACCEs, Cox regression showed that the DD genotype carriers had 2.294-fold relative risk of MACCEs comparing with patients carried II or ID genotype. Conclusion: The NFKB1 gene rs28362491 mutant was an independent predictor of worse long-term prognosis for MACCEs. Therefore, identifying NFKB1 gene rs28362491 mutant may be used as a good way for guiding the standardized management of patients with high-risk of cardiovascular diseases.Keywords
Funding Information
- Natural Science Foundation of Xinjiang Uygur Autonomous Region (2020D01C259)
- National Natural Science Foundation of China (82160054)
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund (SKL-HIDCA-2019-40)
- the Key R&D Program of Xinjiang Uygur Autonomous Region (2020B03002-1, 2020B03002)
This publication has 24 references indexed in Scilit:
- Family history of coronary heart disease and the incidence and progression of coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis, 2014
- Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery diseaseNature Genetics, 2012
- Nuclear factor kappa B (NF-κB): A novel cause for diabetes, coronary artery disease and cancer initiation and promotion?Medical Hypotheses, 2012
- The NFKB1 ATTG ins/del polymorphism and risk of coronary heart disease in three independent populationsAtherosclerosis, 2011
- NF-κB, Inflammation, and Metabolic DiseaseCell Metabolism, 2011
- NFKB1 promoter variation implicates shear-induced NOS3 gene expression and endothelial function in prehypertensives and stage I hypertensivesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Evaluating the role of the genetic variations of PTPN22, NFKB1, and FcGRIIIA genes in inflammatory bowel disease: A meta-analysisInflammatory Bowel Diseases, 2007
- Association of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' diseaseGenes & Immunity, 2007
- Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitisHuman Molecular Genetics, 2004
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary articleJACC, 2002